April 20, 2020 update: CBR seminars have gone virtual! Please contact cbr.progasst@ubc.ca if you’re interested in attending the speaker talks.

2019/20 Seminar Series
Date	Name	Affiliation	Title	Abstract	Host
September 11, 2019	Dr. Paul S. Frenette	Albert Einstein College of Medicine	“Neutrophils, stress and sickle cell disease”		Scott
September 25, 2019	Dr. Ze Zheng	Columbia University Irving Medical Centre	“Hepatocyte tPA: From Liver to Blood and Beyond”		Conway
October 16, 2019	Dr. Eric Mullins	Cincinnati Children’s Hospital Medical Centre	“Should I Stay or Should I Go: Fibrin(ogen) and Fibrinolysis in Neuroinflammation”		Kastrup
November 6, 2019	Dr. Doug Cines	University of Pennsylvania	“Defensins: Link between innate immunity, atherosclerosis and thrombosis”		Kim
January 8, 2020	Dr. Kevin Hay	BC Cancer Research Centre	“CAR-T cell therapy: the experience and the road ahead”		Conway
January 15, 2020	Dr. James Luyendyk	College of Veterinary Medicine at MSU	“Mechanisms linking blood coagulation to liver injury and repair”		Conway
January 29, 2020	Dr. Lubica Rauova	University of Pennsylvania	“Heparin induced thrombocytopenia – therapeutic strategies alternative to anticoagulation.”		Kizhakkedathu
February 5, 2020	Dr. Andrew Shih	Vancouver General Hospital	“What We Don’t Know About Massive Transfusion”		Conway
February 12, 2020	Dr. Gary Gilbert	Harvard Medical School	“Tales of factor VIII inhibitor antibodies: unexpected modulations by platelets and endothelial cells.”		Conway
February 19, 2020	Dr. Timothy Nichols	UNC School of Medicine	“Novel Preclinical Approaches to Hemophilia A Complicated by Inhibitors”		Kastrup
February 27, 2020	Dr. Sergio Martinez-Høyer	Erasmus Medical Centre	“Functional genomics in the pathogenesis of del(5q) myelodysplastic syndromes”		Kastrup/Karsan
March 4, 2020	Dr. Colin Kretz	McMaster University	“High Throughput Protease Profiling to Investigate the Regulation of the Metalloprotease ADAMTS13”		Conway
April 22, 2020	Dr. Ed Conway	UBC	“Complement activation: from atypical HUS to coronavirus-related disease”
April 29, 2020	Diana Canals & Dr. Michael Hughes	UBC	“Podocalyxin as a therapeutic target in cancer” & “Exploring an epigentic link between the gut microbiome and atopic disease”
May 6, 2020	Dr. Mark Scott	UBC	“Immunocamouflage: From Red Cells to Coronavirus”
May 13, 2020	Dr. Paul Jurasz	University of Alberta	“Identification of eNOS-based Platelet and Megakaryocyte Subpopulations”
May 20, 2020	Dr. Ed Pryzdial	UBC	“Antiviral Anticoagulation”
May 27, 2020	Dr. Leonard Foster	UBC	“Identification of unknown snake venom in a toddler”
June 3, 2020	Dr. Mona Khorshidfar	UBC	“Quality measurements of apheresis platelet concentrates from donors whose platelets repeatedly show low pH over storage”
June 10, 2020	Dr. Vijay Akhade	UBC	“miR-146a and p53 regulatory feedback loop in AML”
June 17, 2020	Dr. Christian Kastrup	UBC	“Natural and Novel Modulators of Blood Coagulation: From Soil Silicates in Hemorrhage to Gene Therapy for Thrombosis”
June 24, 2020	Dr. Dana Devine	UBC	“Convalescent Plasma as a therapy for treatment of COVID-19 disease”
July 8, 2020	Hancock Lab	UBC	“From the Outside-In: Treating Biofilm-Associated Infections with Synthetic Host Defence Peptides”
July 15, 2020	Dr. Hélène Côté & Anthony Hsieh	UBC	“HIV and aging – The CARMA cohort”
July 22, 2020	Ma Lab	UBC	“Image Based Cell Phenotyping Using AI” & “Deformability Based Sorting of Red Blood Cells as a Biomarker for Red Blood Cell Quality”
July 29, 2020	Brown Lab	UBC	“Hyaluronan primes the oxidative burst in human neutrophils: implications for inflammation”
August 19, 2020	Melina Messing & Marie-Soleil Smith	UBC	TBA
August 26, 2020	Dr. Jay Kizhakkedathu	UBC	TBA